Integrated Filing- Financial

Ind-Swift Laboratories Ltd. has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. The company's total income stood at ₹72.47 crore with a net profit of ₹11.14 crore, reflecting an increase compared to the previous year.

The board approved the results after review from the Audit Committee, aligning with Indian Accounting Standards.

The company has utilized ₹57.65 crore from a preferential issue of convertible warrants for expansion and working capital, with no deviation in fund utilization.

This may evoke a positive outlook among investors due to solid financial performance and adherence to strategic objectives.